Drug Type Small molecule drug |
Synonyms Alclometasone, Alclometasone dipropionate (JAN/USP) + [11] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (14 Dec 1982), |
Regulation- |
Molecular FormulaC28H37ClO7 |
InChIKeyDJHCCTTVDRAMEH-DUUJBDRPSA-N |
CAS Registry66734-13-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01820 | Alclometasone Dipropionate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dermatitis | GB | 26 Apr 1995 | |
Pruritus | GB | 26 Apr 1995 | |
Eczema | JP | 29 Mar 1988 | |
Erythema | JP | 29 Mar 1988 | |
Insect Bites and Stings | JP | 29 Mar 1988 | |
Keratoderma, Palmoplantar | JP | 29 Mar 1988 | |
Lichen Planus | JP | 29 Mar 1988 | |
Lupus Erythematosus, Discoid | JP | 29 Mar 1988 | |
Prurigo | JP | 29 Mar 1988 | |
Psoriasis | JP | 29 Mar 1988 | |
Purpura | JP | 29 Mar 1988 | |
Roseolovirus Infections | JP | 29 Mar 1988 |
Phase 2 | 236 | (Cohort I: Arm A (Dacomitinib 45 mg + Doxycycline Placebo)) | opuzldtrkw(xviypltjxg) = hnhkothcuf ghthremcmy (tbnusujctd, nsuzdtnieh - qoevmioens) View more | - | 17 Aug 2016 | ||
(Cohort I: Arm B (Dacomitinib 45 mg + Doxycycline 100 mg)) | opuzldtrkw(xviypltjxg) = ynhcoivvnk ghthremcmy (tbnusujctd, xslormitzo - kdgjxoxszp) View more | ||||||
Phase 2 | 112 | Dacomitinib 45 mg + placebo | aomdzldaxx(wzcbocuaez) = improved with prophylactic doxy, but not alclo; prophylactic probiotic was not associated with improved CTCAE or PRO otmlykvrnd (efiivbkhvo ) | - | 08 Sep 2015 | ||